XEM:CA:TSX-iShares MSCI Emerging Markets Index ETF (CAD)

ETF | Emerging Markets Equity |

Last Closing

CAD 34.84

Change

-0.23 (-0.66)%

Market Cap

CAD 0.20B

Volume

2.30K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Emerging Markets Equity

Symbol Name Price(Change) Market Cap
XSEM:CA iShares ESG MSCI Emerging Mark..

-0.43 (-1.93%)

CAD 3.24B
XEC:CA iShares Core MSCI Emerging Mar..

-0.24 (-0.78%)

CAD 1.80B
ZEM:CA BMO MSCI Emerging Markets Inde..

-0.23 (-1.00%)

CAD 1.07B
DRFE:CA Desjardins RI Emerging Markets..

+0.29 (+1.23%)

CAD 0.08B
XMM:CA iShares MSCI Min Vol Emerging ..

+0.17 (+0.56%)

CAD 0.06B
RXD:CA RBC Quant Emerging Markets Div..

-0.08 (-0.36%)

CAD 0.04B
VEE:CA Vanguard FTSE Emerging Markets

-0.40 (-1.00%)

N/A
ZLE:CA BMO Low Volatility Emerging Ma..

N/A

N/A

ETFs Containing XEM:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Emerging Markets Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.26% 44% F 73% C
Dividend Return 0.59% 33% F 18% F
Total Return 18.85% 44% F 70% C-
Trailing 12 Months  
Capital Gain 23.20% 78% C+ 62% D
Dividend Return 2.45% 71% C- 42% F
Total Return 25.65% 78% C+ 61% D-
Trailing 5 Years  
Capital Gain 14.23% 44% F 47% F
Dividend Return 7.40% 40% F 26% F
Total Return 21.63% 56% F 43% F
Average Annual (5 Year Horizon)  
Capital Gain 1.06% N/A N/A 41% F
Dividend Return 2.61% N/A N/A 42% F
Total Return 1.55% N/A N/A 48% F
Risk Return Profile  
Volatility (Standard Deviation) 15.54% N/A N/A 72% C
Risk Adjusted Return 16.78% N/A N/A 39% F
Market Capitalization 0.20B 57% F 46% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike